Valencic E - Search Results

1

From bone marrow transplantation to cellular therapies: possible therapeutic strategies in managing autoimmune disorders.

Taddio A, Biondi A, Piscianz E, Valencic E, Biagi E, Badolato R. Taddio A, et al. Among authors: valencic e. Curr Pharm Des. 2012;18(35):5776-81. doi: 10.2174/138161212803530754. Curr Pharm Des. 2012. PMID: 22726117

2

Medium-term survival without haematopoietic stem cell transplantation in a case of IPEX: insights into nutritional and immunosuppressive therapy.

Taddio A, Faleschini E, Valencic E, Granzotto M, Tommasini A, Lepore L, Andolina M, Barbi E, Ventura A. Taddio A, et al. Among authors: valencic e. Eur J Pediatr. 2007 Nov;166(11):1195-7. doi: 10.1007/s00431-006-0395-6. Epub 2007 Jan 5. Eur J Pediatr. 2007. PMID: 17205241 No abstract available.

3

T cells stimulated in vitro have a suppressive function but do not contain only regulatory T cells.

Valencic E, Piscianz E, Tommasini A, Granzotto M. Valencic E, et al. Clin Exp Immunol. 2007 Dec;150(3):561-6. doi: 10.1111/j.1365-2249.2007.03502.x. Epub 2007 Sep 27. Clin Exp Immunol. 2007. PMID: 17900303 Free PMC article.

4

Regulatory T-cell function is impaired in celiac disease.

Granzotto M, dal Bo S, Quaglia S, Tommasini A, Piscianz E, Valencic E, Ferrara F, Martelossi S, Ventura A, Not T. Granzotto M, et al. Among authors: valencic e. Dig Dis Sci. 2009 Jul;54(7):1513-9. doi: 10.1007/s10620-008-0501-x. Epub 2008 Oct 31. Dig Dis Sci. 2009. PMID: 18975083

5

Selective resistance to different glucocorticoids in severe autoimmune disorders.

Drigo I, Piscianz E, Valencic E, De Iudicibus S, Tommasini A, Ventura A, Decorti G. Drigo I, et al. Among authors: valencic e. Clin Immunol. 2010 Mar;134(3):313-9. doi: 10.1016/j.clim.2009.11.005. Epub 2009 Dec 4. Clin Immunol. 2010. PMID: 19962350

6

The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation.

Valencic E, Piscianz E, Andolina M, Ventura A, Tommasini A. Valencic E, et al. Cytotherapy. 2010 Apr;12(2):154-60. doi: 10.3109/14653240903493417. Cytotherapy. 2010. PMID: 20078387

7

Immunomodulatory drugs in autoimmune lymphoproliferative syndrome (ALPS).

Tommasini A, Valencic E, Piscianz E, Rabusin M. Tommasini A, et al. Among authors: valencic e. Pediatr Blood Cancer. 2012 Feb;58(2):310; author reply 311. doi: 10.1002/pbc.23205. Epub 2011 Jun 14. Pediatr Blood Cancer. 2012. PMID: 21674759 No abstract available.

8

Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes.

Piscianz E, Cuzzoni E, De Iudicibus S, Valencic E, Decorti G, Tommasini A. Piscianz E, et al. Among authors: valencic e. Int Immunopharmacol. 2011 Dec;11(12):2242-5. doi: 10.1016/j.intimp.2011.09.009. Epub 2011 Oct 3. Int Immunopharmacol. 2011. PMID: 21979495

9

Inhibition of mesenchymal stromal cells by pre-activated lymphocytes and their culture media.

Valencic E, Loganes C, Cesana S, Piscianz E, Gaipa G, Biagi E, Tommasini A. Valencic E, et al. Stem Cell Res Ther. 2014 Jan 9;5(1):3. doi: 10.1186/scrt392. Stem Cell Res Ther. 2014. PMID: 24405828 Free PMC article.

10

Fate of lymphocytes after withdrawal of tofacitinib treatment.

Piscianz E, Valencic E, Cuzzoni E, De Iudicibus S, De Lorenzo E, Decorti G, Tommasini A. Piscianz E, et al. Among authors: valencic e. PLoS One. 2014 Jan 9;9(1):e85463. doi: 10.1371/journal.pone.0085463. eCollection 2014. PLoS One. 2014. PMID: 24416411 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters